3 completed, 3 recruiting, 1 not yet recruiting. 3 Phase 2, 2 Phase 3, 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Phase 3 | 2 | Recruiting 2 |
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Curative Surgery: new trials by email Literature Review of Curative Surgery trials Research Report on Curative Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer PD-1 inhibitor, CTLA-4 inhibitor, ctDNA/MRD testing - Colon Cancer, Deficient Mismatch Repair | Phase 2 | Recruiting | Fudan University | 23 | 2026-09-14 | 2026-09-25 |
| Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB) neoadjuvant chemotherapy, curative surgery - Gall Bladder Carcinoma | Phase 3 | Recruiting | Rajiv Gandhi Cancer Institute & Research Center, India | 114 | 2025-01-01 | 2025-04-16 |
| CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence Gemcitabine, Nab paclitaxel, Cisplatin - Biliary Tract Cancer, Cholangiocarcinoma | Phase 2 / Phase 3 | Recruiting | Gruppo Oncologico del Nord-Ovest | 300 | 2023-11-07 | 2026-09-09 |
| Outcome of Neoadjuvant Chemotherapy for Obstructive Colon Cancer Neoadjuvant chemotherapy, Adjuvant chemotherapy, Curative resection - Colon Cancer, Obstruction | Not applicable | Not yet recruiting | The Catholic University of Korea | 204 | 2021-11-01 | 2021-09-22 |
| CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer Nivolumab, Surgery, Radiotherapy, Nivolumab, Surgery, Chemoradiotherapy - Squamous Cell Carcinoma of the Oral Cavity | Phase 2 | Completed | The Clatterbridge Cancer Centre NHS Foundation Trust | 21 | 2019-05-10 | 2025-02-25 |
| HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer Dendritic Cell Vaccine (DC1), Neoadjuvant Chemotherapy, Curative Surgery - Breast Cancer, Breast Cancer Female | Early Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 31 | 2018-06-06 | 2026-09-23 |
| Does Timing of Completion Radical Cholecystectomy Determine the Survival in Incidental Carcinoma Gallbladder Curative surgery - Gall Bladder Carcinoma, Survival | Completed | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 48 | 2009-01-01 | 2021-11-10 |
Colonic Neoplasms (2) · Gallbladder Neoplasms (2) · Biliary Tract Neoplasms (1) · Bites and Stings (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Squamous Cell (1) · Cholangiocarcinoma (1) · Head and Neck Neoplasms (1) · Neoplasm, Residual (1) · Squamous Cell Carcinoma of Head and Neck (1)
Fudan University (1) · Gruppo Oncologico del Nord-Ovest (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Rajiv Gandhi Cancer Institute & Research Center, India (1) · Sanjay Gandhi Postgraduate Institute of Medical Sciences (1) · The Catholic University of Korea (1) · The Clatterbridge Cancer Centre NHS Foundation Trust (1)
China (1) · India (1) · Italy (1) · United Kingdom (1) · United States (1)
Bong-Hyeon Kye, MD.PhD. (1) · Haten Soliman, M.D. (1) · Joseph Sacco, MBChB (1) · Monica Niger, MD (1) · Shivendra Singh, Mch Surgical gastroenterology (1)
PMID 30914290, PMID 30998813, PMID 32528099, PMID 37368098, PMID 38589856, PMID 39901122, PMID 40097486
2017 (1)